RISING INCIDENCE OF FATTY LIVER DISEASE IN YOUNG ADULTS: EPIDEMIOLOGY, RISK FACTORS, AND PUBLIC HEALTH IMPLICATIONS

Authors

  • Dr. AMAN KHANDELWAL
  • Sahibole Mohammed
  • Zunaira Khan

Keywords:

Non-alcoholic fatty liver disease (NAFLD), metabolic dysfunction-associated steatotic liver disease (MASLD), young adults, adolescents, obesity, insulin resistance, epidemiology, liver fibrosis, public health, metabolic syndrome

Abstract

Non-alcoholic fatty liver disease (NAFLD), recently rebranded as metabolic dysfunction-associated steatotic liver disease (MASLD), has emerged as one of the most pressing chronic liver conditions affecting the global population. Historically perceived as a disease of middle-aged and older adults with metabolic comorbidities, NAFLD is now increasingly diagnosed in adolescents and young adults aged 15–39 years. This demographic shift represents a significant public health concern, as early-onset hepatic steatosis provides a longer window for disease progression to non-alcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma.

References

. Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851-861.

2. Global, regional, and national burden of NAFLD in youths and young adults aged 15–39 years, 1990–2021, its attributable risk factors, and projections to 2035: a systematic analysis of the Global Burden of Disease Study 2021. Front Public Health. 2025;13.

3. Le MH, Yeo YH, Li X, et al. 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2022;20(12):2809-2817.

4. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease—Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84.

5. Welsh JA, Karpen S, Vos MB. Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988–1994 to 2007–2010. J Pediatr. 2013;162(3):496-500.

6. Kanwal F, Shubrook JH, Adams LA, et al. Nonalcoholic Fatty Liver Disease Prevalence Trends Among Adolescents and Young Adults in the United States, 2007–2016. Hepatol Commun. 2021;5(11):1977-1989.

7. Younossi ZM, Stepanova M, Ong JP, et al. Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates. Clin Gastroenterol Hepatol. 2019;17(4):748-755.

8. Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73(1):202-209.

9. Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542-1556.

10. Vos MB, Abrams SH, Barlow SE, et al. NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr. 2017;64(2):319-334.

11. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-357.

12. Dyson JK, Anstee QM, McPherson S. Non-alcoholic fatty liver disease: a practical approach to treatment. Frontline Gastroenterol. 2014;5(4):277-286.

13. Romano AD, Serviddio G, de Matthaeis A, Bellanti F, Vendemiale G. Oxidative stress and aging. J Nephrol. 2010;23(Suppl 15):S29-S36.

14. Della Corte C, Mosca A, Maiorani N, et al. Good adherence to the Mediterranean diet reduces the risk for NASH and diabetes in pediatric patients with obesity: The results of an Italian Study. Nutrients. 2017;9(8):770.

15. Katsagoni CN, Georgoulis M, Papatheodoridis GV, Panagiotakos DB, Kontogianni MD. Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis. Metabolism. 2017;68:119-132.

Downloads

Published

2026-05-04

How to Cite

RISING INCIDENCE OF FATTY LIVER DISEASE IN YOUNG ADULTS: EPIDEMIOLOGY, RISK FACTORS, AND PUBLIC HEALTH IMPLICATIONS. (2026). SYNAPSES: INSIGHTS ACROSS THE DISCIPLINES, 3(4), 697-708. https://universalpublishings.com/index.php/siad/article/view/18199